Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Geller

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Blood|June 1, 1989
Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemiaR B Geller, R Saral, S Piantadosi, et al.
Blood|October 1, 1989
A two-step timed sequential treatment for acute myelocytic leukemiaR B Geller, P J Burke, J E Karp, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Bone Marrow Transplantation|February 1, 1996
Association of busulfan area under the curve with veno-occlusive disease following BMTS P Dix, J R Wingard, R E Mullins, et al.
Cytotherapy|December 9, 2003
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind studyS S Joshi, M R Bishop, J C Lynch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.
Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trialJ M Vose, A N Pandite, R A Beveridge, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Blood|June 1, 1989
Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemiaR B Geller, R Saral, S Piantadosi, et al.
Blood|October 1, 1989
A two-step timed sequential treatment for acute myelocytic leukemiaR B Geller, P J Burke, J E Karp, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Bone Marrow Transplantation|February 1, 1996
Association of busulfan area under the curve with veno-occlusive disease following BMTS P Dix, J R Wingard, R E Mullins, et al.
Cytotherapy|December 9, 2003
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind studyS S Joshi, M R Bishop, J C Lynch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxisS M Devine, R B Geller, L B Lin, et al.
Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trialJ M Vose, A N Pandite, R A Beveridge, et al.
Pageof 4